Z-0756-2013 Class II Terminated

Recalled by Becton Dickinson & Company — Franklin Lakes, NJ

FDA device recall Z-0756-2013 was initiated by Becton Dickinson & Company on Nov 12, 2012 and is designated Class II. Reason for recall: BD is conducting a recall of the BD Vacutainer 2.7mL Plus Citrate Blood Collection Tube due to extended Partial Thromboplastin Time (aPTT) test results reported in two customer complaints. The recall status is terminated (terminated Sep 6, 2013). Affected quantity: 2,944,700 units.

Recall details

Product Type
Devices
Report Date
Feb 6, 2013
Initiation Date
Nov 12, 2012
Termination Date
Sep 6, 2013
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2,944,700 units

Product description

BD Vacutainer Buffered Sodium Citrate (9NC) Plus Blood Collection Tubes; Sterile; IVD; REF 363083; 13 X 75 mm, 2.7 mL

Reason for recall

BD is conducting a recall of the BD Vacutainer 2.7mL Plus Citrate Blood Collection Tube due to extended Partial Thromboplastin Time (aPTT) test results reported in two customer complaints.

Distribution pattern

Worldwide Distribution-USA (nationwide) and the countries of Canada, India, Japan, Nepal, Malaysia, Singapore, Brazil, Costa Rica, and Virgin Islands.

Code information

Lot No. 2180434; Expiration Date: April 2013

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0756-2013
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0756-2013. Report a data issue: hello@regdatalab.com.